Text Size

Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder

This study is currently recruiting participants.
Verified July 2012 by VA Eastern Colorado Health Care System
Sponsor:
Information provided by (Responsible Party):
VA Eastern Colorado Health Care System
ClinicalTrials.gov Identifier:
NCT01652430
First received: December 9, 2011
Last updated: July 25, 2012
Last verified: July 2012
History of Changes
  Purpose

This study plans to examine if symptoms of PTSD affect how Veterans who have served in combat think and react to certain information, and whether or not this has an influence on suicidal thoughts.


Condition
PTSD
Suicidal Ideation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by VA Eastern Colorado Health Care System:

Primary Outcome Measures:
  • Beck Scale for Suicidal ideation [ Time Frame: One time ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 95
Study Start Date: October 2010
Estimated Study Completion Date: June 2013
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
PTSD cohort
No PTSD cohort

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

The sample for the current project will be recruited from the group of veterans receiving or eligible to receive outpatient mental health services at the Denver VA Medical Center who have served in combat who may or may not have a diagnosis of PTSD.

Criteria

Inclusion Criteria:

  1. History of combat service
  2. Diagnosis of PTSD confirmed by the CAPS or
  3. No current diagnosis of PTSD
  4. Age 18-65

Exclusion Criteria:

  1. Inability to adequately respond to questions regarding the informed consent procedure.
  2. History of significant neurological disease
  3. Diagnosis of Schizophrenia or other Psychosis
  4. Alcohol abuse/dependence or illicit drug use in the two weeks prior to testing
  5. No history of combat service
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01652430

Contacts
Contact: Nazanin Bahraini, Ph.D. (303)399-8020 ext 5642 Nazanin.Bahraini@va.gov

Locations
United States, Colorado
Denver VA Medical Center Recruiting
Denver, Colorado, United States, 80220
Contact: Nazanin Bahraini, Ph.D.     303-399-8020 ext 5642     Nazanin.Bahraini@va.gov    
Contact: Maria Devore, MS     (303)399-8020 ext 5611     Maria.Devore@va.gov    
Principal Investigator: Nazanin Bahraini, Ph.D.            
Sponsors and Collaborators
VA Eastern Colorado Health Care System
Investigators
Principal Investigator: Nazanin Bahraini, Ph.D. VA Eastern Colorado Healthcare System/MIRECC
  More Information

No publications provided

Responsible Party: VA Eastern Colorado Health Care System
ClinicalTrials.gov Identifier: NCT01652430     History of Changes
Other Study ID Numbers: 10-0159
Study First Received: December 9, 2011
Last Updated: July 25, 2012
Health Authority: United States: Federal Government

Keywords provided by VA Eastern Colorado Health Care System:
PTSD
Suicidal ideation
Cognitive processes

Additional relevant MeSH terms:
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Suicidal Ideation
Anxiety Disorders
 Mental Disorders
Suicide
Self-Injurious Behavior
Behavioral Symptoms

ClinicalTrials.gov processed this record on May 23, 2013